Cargando…
Mechanisms Involved in Microglial-Interceded Alzheimer’s Disease and Nanocarrier-Based Treatment Approaches
Alzheimer’s disease (AD) is a common neurodegenerative disorder accountable for dementia and cognitive dysfunction. The etiology of AD is complex and multifactorial in origin. The formation and deposition of amyloid-beta (Aβ), hyperphosphorylated tau protein, neuroinflammation, persistent oxidative...
Autores principales: | Md, Shadab, Alhakamy, Nabil A., Alfaleh, Mohamed A., Afzal, Obaid, Altamimi, Abdulmalik S. A., Iqubal, Ashif, Shaik, Rasheed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619529/ https://www.ncbi.nlm.nih.gov/pubmed/34834468 http://dx.doi.org/10.3390/jpm11111116 |
Ejemplares similares
-
A technical note on emerging combination approach involved in the onconanotherapeutics
por: Iqubal, Mohammad Kashif, et al.
Publicado: (2022) -
Pathogenic mechanisms and therapeutic promise of phytochemicals and nanocarriers based drug delivery against radiotherapy-induced neurotoxic manifestations
por: Iqubal, Ashif, et al.
Publicado: (2022) -
Signaling Pathway Inhibitors, miRNA, and Nanocarrier-Based Pharmacotherapeutics for the Treatment of Lung Cancer: A Review
por: Md, Shadab, et al.
Publicado: (2021) -
Exploring Nanocarriers as Treatment Modalities for Skin Cancer
por: Adnan, Mohammad, et al.
Publicado: (2023) -
Superficial Dermatophytosis
across the World’s
Populations: Potential Benefits from Nanocarrier-Based Therapies and
Rising Challenges
por: Keshwania, Puja, et al.
Publicado: (2023)